Article By:
Zacks Investment Research
Sunday, January 7, 2024 9:00 AM EDT
Given the continuous need for innovative medical treatments, the biotech industry may be a haven despite its inherent volatility and an uncertain macroeconomic environment. Here are three top biotech stocks that will likely perform well in 2024.
Why Sarepta Therapeutics Inc Looks On Track For A Second DMD Approval
Looks promising, thanks. $SRPT.